WuXi Biologics (Cayman) Inc banner

WuXi Biologics (Cayman) Inc
F:1FW2

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
F:1FW2
Watchlist
Price: 4.35 EUR 1.16% Market Closed
Market Cap: €18.1B

Wall St Price Targets

1FW2 Price Targets Summary
WuXi Biologics (Cayman) Inc

Wall Street analysts forecast 1FW2 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1FW2 is 5.15 EUR with a low forecast of 3.41 EUR and a high forecast of 9.19 EUR.

Lowest Forecast
Price Target
3.41 EUR
22% Downside
Average Forecast
Price Target
5.15 EUR
18% Upside
Highest Forecast
Price Target
9.19 EUR
111% Upside
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
LPA
Two
137% Upside
AGCO
AGCO Corp
6% Upside
VLA
Valneva SE
151% Upside

Revenue
Forecast

44% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
44% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.

Gross Profit
Forecast

49% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
49% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.

Operating Income
Forecast

60% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
60% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.

Pre-Tax Income
Forecast

60% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
60% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 18%.

Net Income
Forecast

60% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
60% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1FW2's stock price target?
Price Target
5.15 EUR

According to Wall Street analysts, the average 1-year price target for 1FW2 is 5.15 EUR with a low forecast of 3.41 EUR and a high forecast of 9.19 EUR.

What is the Revenue forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%

Over the last 10 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 8 years is 11%.

What is the Gross Profit forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
11%

Over the last 10 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 8 years is 11%.

What is the Operating Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
15%

Over the last 10 years, the compound annual growth rate for Operating Income has been 60%. The projected CAGR for the next 8 years is 15%.

What is the Pre-Tax Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
18%

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 60%. The projected CAGR for the next 3 years is 18%.

What is the Net Income forecast for WuXi Biologics (Cayman) Inc?
Projected CAGR
13%

Over the last 10 years, the compound annual growth rate for Net Income has been 60%. The projected CAGR for the next 8 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett